Drug intelligence / Profile preview

diazepam in normal saline

Development stage: Unknown
Lead developer: Roche
Modality: Small Molecules
Administration: Intravenous

Overview

Diazepam in normal saline refers to the preparation of diazepam diluted in normal saline solution for intravenous administration. Diazepam is a benzodiazepine medication that acts as an anxiolytic and has anticonvulsant, sedative, muscle relaxant, and amnestic properties. When administered intravenously, effects begin in one to five minutes and last up to an hour. This preparation is commonly used in clinical settings for the treatment of seizures, status epilepticus, severe anxiety, alcohol withdrawal syndrome, and as premedication before certain medical procedures.

Other names: normal saline + diazepam

Targets

BZD site (GABA-A receptor benzodiazepine site)

Beyond the preview

Go deeper on diazepam in normal saline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on diazepam in normal saline.

Explore the full profile